John Pineda
Impact in
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Virus-based gene therapy research
Papers in
- Oncology 7
- CAR-T cell therapy research 7
-
- Epigenetics and DNA Methylation 2
- Co-authors
- Michel Sadelain (7 shared papers)Claudia Diamonte (6 shared papers)Renier J. Brentjens (5 shared papers)Elizabeth Halton (6 shared papers)Isabelle Rivière (6 shared papers)Navin K. Chintala (3 shared papers)Prasad S. Adusumilli (3 shared papers)Daniel Ngai (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Clinical Cardiology (1 paper)Journal of Hepatology (1 paper)HemaSphere (1 paper)Leukemia (1 paper)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
John Pineda
11 papers receiving 204 citations
Peers
Comparison fields: 5 of 28
- Oncology 174
- Genetics 68
- Immunology 50
- Biotechnology 11
- Biomedical Engineering 51
Countries citing papers authored by John Pineda
This map shows the geographic impact of John Pineda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Pineda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Pineda more than expected).
Fields of papers citing papers by John Pineda
This network shows the impact of papers produced by John Pineda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Pineda. The network helps show where John Pineda may publish in the future.
Co-authors
The 25 scholars most cited alongside John Pineda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 74 | |
| 2 | 2019 | 44 | |
| 3 | 2018 | 37 | |
| 4 | 2021 | 26 | |
| 5 | 2019 | 9 | |
| 6 | 2013 | 5 | |
| 7 | 2018 | 3 | |
| 8 | 2019 | 3 | |
| 9 | 2021 | 2 | |
| 10 | 2020 | 2 | |
| 11 | 2020 | 1 |
About John Pineda
John Pineda is a scholar working on Oncology, Molecular Biology, Genetics, Biotechnology and Immunology, having authored 11 papers that have together received 206 indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Cancer Research and Treatments (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Epigenetics and DNA Methylation (2 papers), Cancer-related molecular mechanisms research (2 papers), Neuroblastoma Research and Treatments (1 paper), Chronic Lymphocytic Leukemia Research (1 paper) and Ultrasound in Clinical Applications (1 paper). The work is most often cited by research in Oncology (174 citations), Genetics (68 citations), Immunology (50 citations), Biotechnology (11 citations) and Biomedical Engineering (51 citations). John Pineda has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Michel Sadelain, Claudia Diamonte, Renier J. Brentjens, Elizabeth Halton, Isabelle Rivière, Navin K. Chintala, Prasad S. Adusumilli, Daniel Ngai, Shanu Modi and Marjorie G. Zauderer. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cardiology, Journal of Hepatology, HemaSphere and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.